A prediction model and risk stratification tool for survival by chemotherapy in invasive micropapillary carcinoma of the breast: a population-based study with external validation - Top-Institutions - MDSpire

A prediction model and risk stratification tool for survival by chemotherapy in invasive micropapillary carcinoma of the breast: a population-based study with external validation

  • By

  • Fang Yang

  • Yiqi Yang

  • Qiuping Xu

  • Lin Tang

  • Yucai Wang

  • Elizabeth J. Cathcart-Rake

  • Li Xie

  • June 4, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Nanjing Drum Tower Hospital
    Nanjing Drum Tower Hospital

    Nanjing, Jiangsu

    Key Differentiators

    • Oncology

  • #2

    North Estonia Medical Centre (NEMC) Foundation
    North Estonia Medical Centre (NEMC) Foundation

    Tallinn, Harju

    Key Differentiators

    • Oncology

  • #3

    Stanford NSCLC Radiogenomics
    Stanford NSCLC Radiogenomics

    Stanford, California

    Key Differentiators

    • Oncology

  • #4

    Georgetown Lombardi Comprehensive Cancer Center
    Georgetown Lombardi Comprehensive Cancer Center

    Washington, District of Columbia

    Key Differentiators

    • Oncology

  • #5

    Childhood Cancer Survivor Study
    Childhood Cancer Survivor Study

    Birmingham, Alabama

    Key Differentiators

    • Oncology

Original Source(s)

A prediction model and risk stratification tool for survival by chemotherapy in invasive micropapillary carcinoma of the breast: a population-based study with external validation

  • by Fang Yang, Yiqi Yang, Qiuping Xu, Lin Tang, Yucai Wang, Elizabeth J. Cathcart-Rake, Li Xie

  • June 4, 2026

Related Content

A patient with triple-negative breast cancer developed acute myocardial infarction after docetaxel chemotherapy: case report and literature review

Development and internal validation of a risk prediction model for ipsilateral upper-limb lymphedema following breast cancer surgery

A multimodal ultrasound-based model combining tumor radiomics and axillary lymph node morphologic classification for predicting axillary nodal burden in breast cancer